Morgan Stanley
IMGN

Morgan Stanley’s Immunogen Inc IMGN Stock Holding History

Morgan Stanley’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,218,354
Closed -$244M – 8094
2023
Q4 		$244M Buy
8,218,354
+3,389,263
+70% +$67.5M 0.01% 1031
2023
Q3 		$76.6M Buy
4,829,091
+1,490,486
+45% +$24.8M 0.01% 1240
2023
Q2 		$63M Sell
3,338,605
-3,981,093
-54% -$47M 0.01% 1397
2023
Q1 		$28.1M Buy
7,319,698
+3,064,478
+72% +$13.1M ﹤0.01% 2072
2022
Q4 		$21.1M Sell
4,255,220
-488,254
-10% -$2.65M ﹤0.01% 2283
2022
Q3 		$22.7M Sell
4,743,474
-742,293
-14% -$3.91M ﹤0.01% 2060
2022
Q2 		$24.7M Buy
5,485,767
+241,147
+5% +$1.05M ﹤0.01% 2048
2022
Q1 		$25M Buy
5,244,620
+1,037,265
+25% +$5.74M ﹤0.01% 1883
2021
Q4 		$31.2M Buy
4,207,355
+443,017
+12% +$2.75M ﹤0.01% 1711
2021
Q3 		$21.3M Sell
3,764,338
-522,163
-12% -$3.02M ﹤0.01% 2021
2021
Q2 		$28.2M Buy
4,286,501
+82,522
+2% +$576K ﹤0.01% 1793
2021
Q1 		$34.1M Sell
4,203,979
-442,260
-10% -$3.61M 0.01% 1472
2020
Q4 		$30M Buy
4,646,239
+2,850,590
+159% +$16.6M ﹤0.01% 1473
2020
Q3 		$6.46M Buy
1,795,649
+1,138,933
+173% +$4.6M ﹤0.01% 2466
2020
Q2 		$3.02M Sell
656,716
-73,944
-10% -$314K ﹤0.01% 3184
2020
Q1 		$2.49M Sell
730,660
-3,702,036
-84% -$16.2M ﹤0.01% 3160
2019
Q4 		$22.6M Buy
4,432,696
+1,686,844
+61% +$5.72M 0.01% 1548
2019
Q3 		$6.65M Sell
2,745,852
-3,088,015
-53% -$8.2M ﹤0.01% 2563
2019
Q2 		$12.7M Buy
5,833,867
+2,493,037
+75% +$5.9M ﹤0.01% 1914
2019
Q1 		$9.05M Sell
3,340,830
-2,019,368
-38% -$8.75M ﹤0.01% 2127
2018
Q4 		$25.7M Buy
5,360,198
+2,553,720
+91% +$15.5M 0.01% 1240
2018
Q3 		$26.6M Sell
2,806,478
-719,297
-20% -$6.91M 0.01% 1429
2018
Q2 		$34.3M Sell
3,525,775
-129,035
-4% -$1.36M 0.01% 1153
2018
Q1 		$38.4M Sell
3,654,810
-241,900
-6% -$2.39M 0.01% 1101
2017
Q4 		$25M Buy
3,896,710
+2,908,201
+294% +$17.9M 0.01% 1473
2017
Q3 		$7.56M Sell
988,509
-35,961
-4% -$239K ﹤0.01% 2557
2017
Q2 		$7.28M Sell
1,024,470
-174,123
-15% -$797K ﹤0.01% 2464
2017
Q1 		$4.64M Sell
1,198,593
-68,374
-5% -$200K ﹤0.01% 2930
2016
Q4 		$2.58M Buy
1,266,967
+135,906
+12% +$273K ﹤0.01% 3689
2016
Q3 		$3.03M Sell
1,131,061
-1,355,601
-55% -$3.94M ﹤0.01% 3155
2016
Q2 		$7.66M Buy
2,486,662
+1,597,394
+180% +$10M ﹤0.01% 2211
2016
Q1 		$7.58M Buy
889,268
+63
+0% +$533 ﹤0.01% 2113
2015
Q4 		$12.1M Sell
889,205
-43,478
-5% -$535K ﹤0.01% 1806
2015
Q3 		$8.95M Sell
932,683
-164,144
-15% -$2.4M ﹤0.01% 2068
2015
Q2 		$15.8M Buy
1,096,827
+157,564
+17% +$1.73M 0.01% 1698
2015
Q1 		$8.41M Sell
939,263
-59,281
-6% -$429K ﹤0.01% 2251
2014
Q4 		$6.09M Buy
998,544
+2,550
+0.3% +$23.3K ﹤0.01% 2536
2014
Q3 		$10.5M Buy
995,994
+169,029
+20% +$1.91M ﹤0.01% 1972
2014
Q2 		$9.8M Buy
826,965
+509,837
+161% +$6.4M ﹤0.01% 2051
2014
Q1 		$4.74M Sell
317,128
-76,497
-19% -$1.21M ﹤0.01% 2633
2013
Q4 		$5.77M Sell
393,625
-69,487
-15% -$1.07M ﹤0.01% 2445
2013
Q3 		$7.88M Buy
463,112
+14,371
+3% +$253K ﹤0.01% 1985
2013
Q2 		$7.44M Buy
+448,741
New +$7.27M ﹤0.01% 1952

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Morgan Stanley's IMGN Position: Q1 2024 in Review

Morgan Stanley sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 8,218,354 shares — an estimated $244M sold.

Morgan Stanley first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $244M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Morgan Stanley reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 8,218,354 Immunogen Inc shares in Q1 2024, an estimated $244M.
  • Morgan Stanley first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Morgan Stanley's Immunogen Inc position peaked at $244M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.